Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Separation and Purification. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced purification patent CN103467310B ensures high purity chiral intermediate for Linezolid and Rivaroxaban with scalable manufacturing capabilities.